BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 29624735)

  • 1. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
    Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease.
    Subbarayan MS; Hudson C; Moss LD; Nash KR; Bickford PC
    J Neuroinflammation; 2020 Aug; 17(1):242. PubMed ID: 32799878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell senescence induced by toxic interaction between α-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease.
    Shen QQ; Jv XH; Ma XZ; Li C; Liu L; Jia WT; Qu L; Chen LL; Xie JX
    Acta Pharmacol Sin; 2024 Feb; 45(2):268-281. PubMed ID: 37674042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease.
    George S; Rey NL; Tyson T; Esquibel C; Meyerdirk L; Schulz E; Pierce S; Burmeister AR; Madaj Z; Steiner JA; Escobar Galvis ML; Brundin L; Brundin P
    Mol Neurodegener; 2019 Aug; 14(1):34. PubMed ID: 31419995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain.
    Thakur P; Breger LS; Lundblad M; Wan OW; Mattsson B; Luk KC; Lee VMY; Trojanowski JQ; Björklund A
    Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8284-E8293. PubMed ID: 28900002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-induced Reactive Astrogliosis Exacerbates the Pathology of Parkinson's Disease.
    An H; Lee H; Yang S; Won W; Lee CJ; Nam MH
    Exp Neurobiol; 2021 Jun; 30(3):222-231. PubMed ID: 34045369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein inclusion responsive microglia are resistant to CSF1R inhibition.
    Stoll AC; Kemp CJ; Patterson JR; Kubik M; Kuhn N; Benskey M; Duffy MF; Luk KC; Sortwell CE
    J Neuroinflammation; 2024 Apr; 21(1):108. PubMed ID: 38664840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GV-971 attenuates α-Synuclein aggregation and related pathology.
    Yu Z; Yang Y; Chan RB; Shi M; Stewart T; Huang Y; Liu Z; Lan G; Sheng L; Tian C; Yang D; Zhang J
    CNS Neurosci Ther; 2024 Feb; 30(2):e14393. PubMed ID: 37563872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of alpha-synuclein oligomers in preclinical models of Parkinson's disease by electrical stimulation in vitro and deep brain stimulation in vivo.
    Lee EJ; Aguirre-Padilla DH; Fomenko A; Pawar G; Kapadia M; George J; Lozano AM; Hamani C; Kalia LV; Kalia SK
    Brain Stimul; 2024; 17(2):166-175. PubMed ID: 38342364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1.
    Li Y; Wang Y; Kou L; Yin S; Chi X; Sun Y; Wu J; Jin Z; Zhou Q; Zou W; Wang T; Xia Y
    CNS Neurosci Ther; 2024 May; 30(5):e14738. PubMed ID: 38702933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A
    Hu Q; Xu L; Liu X; Wang Y; Yuan J
    Neurosci Lett; 2024 Mar; 826():137610. PubMed ID: 38157926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen degrades α-synuclein, Tau and TDP-43 and decreases dopaminergic neurodegeneration in mouse models of Parkinson's disease.
    Guo C; Wang T; Huang H; Wang X; Jiang Y; Li J
    Sci Rep; 2024 Apr; 14(1):8581. PubMed ID: 38615036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of green tea extract (-)-epigallocatechin-3-gallate in a preformed fibril-induced mouse model of Parkinson's disease.
    Shen J; Xie J; Ye L; Mao J; Sun S; Chen W; Wei S; Ruan S; Wang L; Hu H; Wei J; Zheng Y; Xi Z; Wang K; Xu Y
    Neuroreport; 2024 Apr; 35(6):421-430. PubMed ID: 38526966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usp14 deficiency removes α-synuclein by regulating S100A8/A9 in Parkinson's disease.
    Ding L; Lu L; Zheng S; Zhang Z; Huang X; Ma R; Zhang M; Xu Z; Chen M; Guo Z; Zhu S; Gong J; Mao H; Zhang W; Xu P
    Cell Mol Life Sci; 2024 May; 81(1):232. PubMed ID: 38780644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A53T α-synuclein mutation increases susceptibility to postoperative delayed neurocognitive recovery via hippocampal Ang-(1-7)/MasR axis.
    Hong J; Li Y; Chen L; Han D; Li Y; Mi X; Liu K; Wang Q; Song Y; Liu T; Yang N; Liu Y; Li Z; Guo X
    Biochem Pharmacol; 2024 Jun; 224():116261. PubMed ID: 38705534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretome of bone marrow mesenchymal stromal cells cultured in a dynamic system induces neuroprotection and modulates microglial responsiveness in an α-synuclein overexpression rat model.
    Marques CR; Campos J; Sampaio-Marques B; Antunes FF; Dos Santos Cunha RM; Silva D; Barata-Antunes S; Lima R; Fernandes-Platzgummer A; da Silva CL; Sousa RA; Salgado AJ
    Cytotherapy; 2024 Feb; ():. PubMed ID: 38483360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy.
    Parmasad JA; Ricke KM; Nguyen B; Stykel MG; Buchner-Duby B; Bruce A; Geertsma HM; Lian E; Lengacher NA; Callaghan SM; Joselin A; Tomlinson JJ; Schlossmacher MG; Stanford WL; Ma J; Brundin P; Ryan SD; Rousseaux MWC
    Cell Death Dis; 2024 Apr; 15(4):246. PubMed ID: 38575601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gardenin A treatment attenuates inflammatory markers, synuclein pathology and deficits in tyrosine hydroxylase expression and improves cognitive and motor function in A53T-α-syn mice.
    Hack W; Gladen-Kolarsky N; Chatterjee S; Liang Q; Maitra U; Ciesla L; Gray NE
    Biomed Pharmacother; 2024 Apr; 173():116370. PubMed ID: 38458012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-protein interactions regulating α-synuclein pathology.
    Wang J; Dai L; Chen S; Zhang Z; Fang X; Zhang Z
    Trends Neurosci; 2024 Mar; 47(3):209-226. PubMed ID: 38355325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Models of α-synuclein aggregation in Parkinson's disease.
    Giráldez-Pérez R; Antolín-Vallespín M; Muñoz M; Sánchez-Capelo A
    Acta Neuropathol Commun; 2014 Dec; 2():176. PubMed ID: 25497491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.